Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 1
2013 4
2014 6
2015 6
2016 4
2017 3
2018 3
2019 13
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for yiming zhong
Search for Biming Zhong instead (1 results)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Dubovsky JA, Beckwith KA, Natarajan G, Woyach JA, Jaglowski S, Zhong Y, Hessler JD, Liu TM, Chang BY, Larkin KM, Stefanovski MR, Chappell DL, Frissora FW, Smith LL, Smucker KA, Flynn JM, Jones JA, Andritsos LA, Maddocks K, Lehman AM, Furman R, Sharman J, Mishra A, Caligiuri MA, Satoskar AR, Buggy JJ, Muthusamy N, Johnson AJ, Byrd JC. Dubovsky JA, et al. Among authors: zhong y. Blood. 2013 Oct 10;122(15):2539-49. doi: 10.1182/blood-2013-06-507947. Epub 2013 Jul 25. Blood. 2013. PMID: 23886836 Free PMC article. Clinical Trial.
TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J, Li H, Shi M, Zhu Y, Ma Y, Zhong Y, Xiong C, Chen H, Peng C. Wu J, et al. Among authors: zhong y. J Exp Clin Cancer Res. 2019 Aug 9;38(1):348. doi: 10.1186/s13046-019-1334-5. J Exp Clin Cancer Res. 2019. PMID: 31399111 Free PMC article.
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
Stiff A, Trikha P, Wesolowski R, Kendra K, Hsu V, Uppati S, McMichael E, Duggan M, Campbell A, Keller K, Landi I, Zhong Y, Dubovsky J, Howard JH, Yu L, Harrington B, Old M, Reiff S, Mace T, Tridandapani S, Muthusamy N, Caligiuri MA, Byrd JC, Carson WE 3rd. Stiff A, et al. Among authors: zhong y. Cancer Res. 2016 Apr 15;76(8):2125-36. doi: 10.1158/0008-5472.CAN-15-1490. Epub 2016 Feb 15. Cancer Res. 2016. PMID: 26880800 Free PMC article.
MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
Zhu Y, Gu J, Li Y, Peng C, Shi M, Wang X, Wei G, Ge O, Wang D, Zhang B, Wu J, Zhong Y, Shen B, Chen H. Zhu Y, et al. Among authors: zhong y. Cancer Lett. 2018 Jan 1;412:59-68. doi: 10.1016/j.canlet.2017.09.044. Epub 2017 Oct 4. Cancer Lett. 2018. PMID: 28987387 Free article.
Identification of Key Transcription Factors AP-1 and AP-1-Dependent miRNAs Forming a Co-Regulatory Network Controlling PTEN in Liver Ischemia/Reperfusion Injury.
Zhong Y, Zhu Y, Dong J, Zhou W, Xiong C, Xue M, Shi M, Chen H. Zhong Y, et al. Biomed Res Int. 2019 Nov 5;2019:8962682. doi: 10.1155/2019/8962682. eCollection 2019. Biomed Res Int. 2019. PMID: 31781649 Free PMC article.
Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China.
Zhong YM, Liu WE, Zheng ZF. Zhong YM, et al. Infect Drug Resist. 2019 Jul 12;12:2069-2076. doi: 10.2147/IDR.S209877. eCollection 2019. Infect Drug Resist. 2019. PMID: 31372014 Free PMC article.
Constraining Dissipative Dark Matter Self-Interactions.
Essig R, McDermott SD, Yu HB, Zhong YM. Essig R, et al. Phys Rev Lett. 2019 Sep 20;123(12):121102. doi: 10.1103/PhysRevLett.123.121102. Phys Rev Lett. 2019. PMID: 31633968
Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis.
Wei C, Wen-En L, Yang-Ming L, Shan L, Yi-Ming Z. Wei C, et al. Arch Med Sci. 2015 Oct 12;11(5):927-36. doi: 10.5114/aoms.2015.54846. Arch Med Sci. 2015. PMID: 26528332 Free PMC article. Review.
47 results
Jump to page